Despite the harmful effects of AngII, the non-classical Ang1–7/Mas receptor axis, provides protection against renal dysfunction, fibrosis, apoptosis, and glomerulosclerosis, and the MasR antagonist (A779) or gene deletion of the MasR inhibited these beneficial effects (8, 9). Here, MAS1L is linked to glomerulosclerosis.